Market Overview

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

424.02 +9.05 (2.18%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/04/19GuggenheimUpgradesBuy0.0
12/14/18Goldman SachsUpgradesBuy0.0
10/11/18Morgan StanleyMaintainsEqual-Weight412.0
10/11/18Canaccord GenuityMaintainsHold410.0
10/01/18Cantor FitzgeraldInitiates Coverage OnNeutral415.0
8/06/18BarclaysMaintainsUnderweight305.0
8/03/18Canaccord GenuityMaintainsHold390.0
8/03/18Morgan StanleyMaintainsEqual-Weight409.0
8/03/18BairdDowngradesNeutral0.0
7/16/18ArgusMaintainsBuy415.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter